glukosmetabola

Glukosmetabola refers to the cellular and systemic processes that manage the uptake, conversion, storage, and utilization of glucose to meet energy and biosynthetic needs. It encompasses multiple interrelated pathways that operate in different tissues, notably the liver, muscle, adipose tissue, and the brain, and tightly coordinated hormonal regulation.

Key pathways include glycolysis, the cytosolic breakdown of glucose to pyruvate with a net production of two ATP molecules per glucose and two NADH molecules. If oxygen is present, pyruvate typically enters mitochondria and is converted to acetyl-CoA, feeding the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to yield much more ATP. In anaerobic conditions, pyruvate can be reduced to lactate. The pentose phosphate pathway generates NADPH and ribose-5-phosphate for biosynthesis. Glycogen metabolism stores glucose as glycogen (glycogenesis) and releases it when needed (glycogenolysis), primarily in liver and muscle. Gluconeogenesis synthesizes glucose from non-carbohydrate substrates in liver and kidney, helping maintain blood glucose during fasting.

Regulation is driven by hormones and nutrient status. Insulin promotes glucose uptake (via GLUT4 in muscle and fat), glycolysis, and glycogen synthesis, while glucagon and epinephrine stimulate glycogenolysis and gluconeogenesis during fasting. Brain, erythrocytes, and other glucose-dependent tissues rely on glucose as a key energy source, influencing overall energy homeostasis and substrate balance.

Dysregulation of glukosmetabola is central to conditions such as diabetes mellitus, obesity-related metabolic disorders, and various inherited disorders affecting glycolysis, gluconeogenesis, or glycogen metabolism.